For: | Ong LT. Evidence based review of management of cardiorenal syndrome type 1. World J Methodol 2021; 11(4): 187-198 [PMID: 34322368 DOI: 10.5662/wjm.v11.i4.187] |
---|---|
URL: | https://www.wjgnet.com/2222-0682/full/v11/i4/187.htm |
Number | Citing Articles |
1 |
Svetlana Kazaryan, Rimma Bazarbekova, Ainur Dossanova, Nazgul Kainarbekova, Aigerim Zhakebayeva. Functional state of the kidneys in patients with acute coronary syndrome against the background of newly identified disorders of carbohydrate metabolism: a multidisciplinary problem. Expert Review of Endocrinology & Metabolism 2024; 19(5): 437 doi: 10.1080/17446651.2024.2363543
|
2 |
Wei-Chieh Lee, Po-Jui Wu, Hsiu-Yu Fang, Yen-Nan Fang, Huang-Chung Chen, Meng-Shen Tong, Pei-Hsun Sung, Chieh-Ho Lee, Wen-Jung Chung. Levosimendan Administration May Provide More Benefit for Survival in Patients with Non-Ischemic Cardiomyopathy Experiencing Acute Decompensated Heart Failure. Journal of Clinical Medicine 2022; 11(14): 3997 doi: 10.3390/jcm11143997
|
3 |
Julija G. Voicehovska, Dace Trumpika, Vladimirs V. Voicehovskis, Eva Bormane, Inara Bušmane, Anda Grigane, Eva Moreino, Aivars Lejnieks. Cardiovascular Consequences of Acute Kidney Injury: Treatment Options. Biomedicines 2023; 11(9): 2364 doi: 10.3390/biomedicines11092364
|
4 |
Chang-Shou She, Yue-Lin Deng, Guo-Qing Huang, Chao Cheng, Fang-Jie Zhang. Risk Factors and Outcome Variables of Cardiorenal Syndrome Type 1 in Acute Myocardial Infarction Patients. International Journal of General Medicine 2022; : 1565 doi: 10.2147/IJGM.S350361
|